Industry Innovation and Science Australia

Main content area

Industry Innovation and Science Australia logo

We are an independent statutory board of entrepreneurs, investors, researchers and educators. We advise the Australian Government on innovation, research and science matters.

Venture Capital Tax Concessions Review

Industry Innovation and Science Australia and the Treasury are undertaking a review of venture capital tax concession programs.

The review was publicly announced as part of the government’s Digital Economy Strategy in the 2021–22 Budget.

The review will consider the:

  • Venture Capital Limited Partnerships
  • Early Stage Venture Capital Limited Partnerships
  • Australian Venture Capital Fund of Funds.

Public consultation will inform the review.

Read more:

Driving effective Government investment in innovation, science and research 

Our report Driving effective Government investment in innovation, science and research, reviews the effectiveness of the Australian Government's investment in, and the performance of, the Australian innovation, science and research system.

Stimulating business investment in innovation

Our report, Stimulating business investment in innovation, outlines strategic recommendations for Australian Government and businesses to encourage greater investment in Australian innovation.

Who we are

Our board members have extensive local and global experience in innovation, science and research.

See our:  

We are supported by the Office of Industry Innovation and Science Australia.

What we do

Industry Innovation and Science Australia (IISA) will play a key advisory role in implementing the government’s $1.5 billion Modern Manufacturing Strategy.

IISA will also continue to:

  • advise on all innovation and science matters
  • inform and guide policy on industry, innovation, science and research
  • advocate and champion Australia’s innovation, science and research system.

Statement of expectations and intent

If you're having difficult accessing any of our documents, please contact us.